We serve Chemical Name:tert-butyl 3-[3-(trifluoromethyl)anilino]piperidine-1-carboxylate CAS:887585-04-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
![tert-butyl 3-[3-(trifluoromethyl)anilino]piperidine-1-carboxylate](https://a.dearchem.com/CAS2/887585-04-8.png)
Chemical Name:tert-butyl 3-[3-(trifluoromethyl)anilino]piperidine-1-carboxylate
CAS.NO:887585-04-8
Synonyms:1-boc-3-(3-trifluoromethylphenylamino)-piperidine;tert-Butyl 3-{[3-(Trifluoromethyl)phenyl]amino}piperidine-1-carboxylate;tert-butyl 3-{[3-(trifluoromethyl)phenyl]amino}piperidinecarboxylate;1-Piperidinecarboxylicacid,3-[[3-(trifluoromethyl)phenyl]amino]-,1,1-dimethylethyl ester
Molecular Formula:C17H23F3N2O2
Molecular Weight:344.37200
HS Code:2933399090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:41.57000
Exact Mass:344.17100
LogP:4.52770
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 1-boc-3-(3-trifluoromethylphenylamino)-piperidine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-Piperidinecarboxylicacid,3-[[3-(trifluoromethyl)phenyl]amino]-,1,1-dimethylethyl ester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,tert-Butyl 3-{[3-(Trifluoromethyl)phenyl]amino}piperidine-1-carboxylate Use and application,tert-butyl 3-{[3-(trifluoromethyl)phenyl]amino}piperidinecarboxylate technical grade,usp/ep/jp grade.
Related News: If the government does not close the border and heed their other demands by 9 p.m., union members handling emergency services would also strike, the union said. tert-butyl 3-[3-(trifluoromethyl)anilino]piperidine-1-carboxylate manufacturer I’ve had successful major surgery to remove it, and I’m now undergoing several months of chemotherapy for the very best possible long-term prognosis, and I’m confident,” she said Monday at the beginning of her daily television program, CNN reported.
Amanpour, 63, has been off work for the past four weeks due to her condition. As she undergoes chemotherapy, she expects to anchor Mondays through Wednesdays. She also has three weeks of previously booked time off that starts at the end of June.
Amanpour noted that ovarian cancer is all too common, affecting “millions of women around the world. tert-butyl 3-[3-(trifluoromethyl)anilino]piperidine-1-carboxylate supplier If the government does not close the border and heed their other demands by 9 p.m., union members handling emergency services would also strike, the union said. tert-butyl 3-[3-(trifluoromethyl)anilino]piperidine-1-carboxylate vendor Rigosertib, Onconova��s lead candidate, is a proprietary Phase 3 small molecule. tert-butyl 3-[3-(trifluoromethyl)anilino]piperidine-1-carboxylate factory Novavax, a Maryland biotechnology company that has struggled mightily with delays in developing its coronavirus vaccine, announced Monday that its two-shot regimen was over 90% effective overall in a trial that unfolded even as more contagious variants emerged.
Amanpour, 63, has been off work for the past four weeks due to her condition. As she undergoes chemotherapy, she expects to anchor Mondays through Wednesdays. She also has three weeks of previously booked time off that starts at the end of June.
Amanpour noted that ovarian cancer is all too common, affecting “millions of women around the world. tert-butyl 3-[3-(trifluoromethyl)anilino]piperidine-1-carboxylate supplier If the government does not close the border and heed their other demands by 9 p.m., union members handling emergency services would also strike, the union said. tert-butyl 3-[3-(trifluoromethyl)anilino]piperidine-1-carboxylate vendor Rigosertib, Onconova��s lead candidate, is a proprietary Phase 3 small molecule. tert-butyl 3-[3-(trifluoromethyl)anilino]piperidine-1-carboxylate factory Novavax, a Maryland biotechnology company that has struggled mightily with delays in developing its coronavirus vaccine, announced Monday that its two-shot regimen was over 90% effective overall in a trial that unfolded even as more contagious variants emerged.
